Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 2

OncLive

Six months after receiving a second dose of the Pfizer-BioNTech COVID-19 vaccine, patients with solid tumors retained similar levels of COVID-19 antibodies in their

  • Six months after receiving a second dose of the Pfizer-BioNTech COVID-19 vaccine, patients with solid tumors retained similar levels of COVID-19 antibodies in their blood as individuals without cancer. #COVID19 #oncology #MedTwitter https://t.co/tiVllSmY7C - view on twitter